Potomac, MD, United States of America

J Leslie Glick


Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1985-1991

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of J Leslie Glick in Dementia Diagnosis and Management

Introduction

J Leslie Glick, based in Potomac, MD, is a notable inventor with a focus on medical innovations, specifically in the field of dementia. With a total of five patents to his name, Glick has contributed significantly to the diagnosis and management of neurodegenerative diseases, particularly Alzheimer's disease (AD).

Latest Patents

Among his latest patents are methods for diagnosing, monitoring, and controlling the onset and progression of certain dementias. These innovative methods revolve around the analysis of changes in the relative concentrations of two forms of albumin in either serum or cerebrospinal fluid (CSF). Glick's research demonstrates that monitoring these changes can provide vital insights into the onset and progression of dementia. Furthermore, his work suggests that dietary supplementation or administration of magnesium can impede memory loss or improve memory impairment.

Career Highlights

Throughout his career, Glick has been associated with reputable companies such as Bionix, Inc. and Genex Corporation, where his expertise in biomedical innovations has flourished. His contributions to these organizations have advanced the understanding and treatment of cognitive disorders.

Collaborations

J Leslie Glick has collaborated with notable professionals in the field, including Donald R. Durham and Douglas W. Fodge. These partnerships have enhanced the research and development efforts surrounding his patented technologies, further solidifying their potential impact on dementia treatment.

Conclusion

In summary, J Leslie Glick's innovative work and patents represent significant advancements in the diagnosis and management of dementia. His research not only paves the way for improved understanding of neurodegenerative diseases but also offers potential solutions for optimizing patient care. Through continued collaboration and innovation, Glick's contributions are poised to make a lasting impact in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…